Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
278 participants
OBSERVATIONAL
2023-10-01
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
TSH Risk by Extraction Site in Lap Cholecystectomy
NCT06953713
Evaluation of Laparoscopic Cholecystectomy and Concomitant Paraumbilical Hernia Repair
NCT06317779
Video-assisted Umbilical Fascial Closure in Laparoscopic Cholecystectomy
NCT05208385
Risk of Umbilical Trocar-site Hernia After SILC Cholecystectomy Versus Conventional Cholecystectomy
NCT01740973
Post-ERCP Cholecystectomy. How ERCP and ERCP-related Variables Effect the Outcomes?
NCT06388525
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Researchers aim to determine the exact prevalence and risk factors for the association of gallstones and umbilical hernia. Umbilical hernia is defined according to the European Hernia Society Classification for primary and incisional abdominal wall hernias as hernias occurring from 3 cm above to 3 cm below the umbilicus. The main outcome measures are the presence of gallstones in patients presenting with umbilical hernia and the presence of umbilical hernia in patients diagnosed with gallstones. Patients with umbilical hernia are examined with biliary ultrasound, while patients with cholelithiasis are evaluated for umbilical hernia by physical examination and ultrasound. Factors such as age, gender, body mass index (BMI), family history, comorbidities, tobacco use, parity, and history of multiple pregnancy are analyzed as potential risk factors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cholelithiasis Group
It is determined whether there is an umbilical hernias in patients with cholelithiasis
Umbilical region superficial tissue ultrasound
The presence of umbilical hernia in patients with cholelithiasis is detected by ultrasound of the superficial tissue of the umbilical region.
Umbilical Hernia Group
It is determined whether patients with umbilical hernia have cholelithiasis or not.
Hepatobiliary ultrasound
The presence of cholelithiasis in patients with umbilical hernia is detected by hepatobiliary ultrasound
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hepatobiliary ultrasound
The presence of cholelithiasis in patients with umbilical hernia is detected by hepatobiliary ultrasound
Umbilical region superficial tissue ultrasound
The presence of umbilical hernia in patients with cholelithiasis is detected by ultrasound of the superficial tissue of the umbilical region.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with cholelithiasis
Exclusion Criteria
* Having undergone abdominal surgery with a median line incision
* having collagen tissue disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Konya Meram State Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alpaslan Şahin
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alpaslan Sahin, MD
Role: PRINCIPAL_INVESTIGATOR
Konya Meram State Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Konya Training and Research Hospital
Konya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hernia Study Group
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.